Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose for minimal hepatic encephalopathy in cirrhosis
ChiCTR-TRC-12002342Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactulose in hepatic encephalopathy (HE) and Cirrhosis (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Recovery rate of both abnormal NCT and DST. Started Aug 2012; status: completed.
02
Drugs
lactulose
03
Conditions
hepatic encephalopathy (HE)Cirrhosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002342.